Nxera Pharma Co., Ltd. Logo

Nxera Pharma Co., Ltd.

4565 | T

Overview

Corporate Details

ISIN(s):
N/A
LEI:
Country:
Japan
Address:
港区赤坂9−7−2
Sector:
Health Care
Industry:
Pharmaceuticals

Description

Nxera Pharma Co., Ltd. is a pioneering Japanese biopharmaceutical company dedicated to revolutionizing medicine through advanced science and technology. With a mission to accelerate the development of life-changing therapies, Nxera focuses on creating innovative solutions that enhance patient care. The company is committed to pushing the boundaries of drug design, specifically through its expertise in structure-based methodologies. By forging strategic partnerships and pursuing groundbreaking discoveries, Nxera aims to bring forth the next generation of medical treatments. With a robust pipeline and a dedication to addressing unmet medical needs, Nxera Pharma is at the forefront of delivering better health outcomes for patients worldwide.

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
2025-04-16 08:57
Regulatory News Service
訂正有価証券届出書(参照方式)
Japanese 41.6 KB
2025-04-16 08:55
Regulatory News Service
訂正有価証券届出書(参照方式)
Japanese 41.6 KB
2025-04-16 08:53
Regulatory News Service
訂正有価証券届出書(参照方式)
Japanese 39.8 KB
2025-04-16 08:51
Inside Information Statement
臨時報告書
Japanese 32.4 KB
2025-03-26 08:42
Regulatory News Service
訂正有価証券届出書(参照方式)
Japanese 42.2 KB
2025-03-26 08:41
Regulatory News Service
訂正有価証券届出書(参照方式)
Japanese 42.2 KB
2025-03-26 08:40
Regulatory News Service
訂正有価証券届出書(参照方式)
Japanese 40.4 KB
2025-03-26 08:38
Inside Information Statement
臨時報告書
Japanese 28.0 KB
2025-03-26 08:37
Internal Control over Financial Reporting
内部統制報告書-第35期(2024/01/01-2024/12/31)
Japanese 23.8 KB
2025-03-26 08:36
Regulatory News Service
確認書
Japanese 8.6 KB
2025-03-26 08:35
Annual Report
有価証券報告書-第35期(2024/01/01-2024/12/31)
Japanese 1.3 MB
2025-02-14 07:47
Regulatory News Service
訂正有価証券届出書(参照方式)
Japanese 38.2 KB
2025-02-14 07:46
Regulatory News Service
訂正有価証券届出書(参照方式)
Japanese 38.2 KB
2025-02-14 07:45
Regulatory News Service
訂正有価証券届出書(参照方式)
Japanese 36.4 KB
2024-08-09 09:10
Regulatory News Service
訂正有価証券届出書(参照方式)
Japanese 41.7 KB

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
NIPPON CHEMIPHAR CO., LTD. Logo NIPPON CHEMIPHAR CO., LTD. Japan 4539
Nippon Shinyaku Co.,Ltd. Logo Nippon Shinyaku Co.,Ltd. Japan 4516
Noile-Immune Biotech Inc. Logo Noile-Immune Biotech Inc. Japan 4893
Novartis AG Logo Novartis AG Switzerland NOVN
Nur Ink Innovations Ltd. Logo Nur Ink Innovations Ltd. Israel NURI
ObsEva SA Logo ObsEva SA Switzerland OBSN
ODI Pharma AB Logo ODI Pharma AB Sweden ODI
Oncolys BioPharma Inc. Logo Oncolys BioPharma Inc. Japan 4588
OncoTherapy Science, Inc. Logo OncoTherapy Science, Inc. Japan 4564
OncoZenge AB Logo OncoZenge AB Sweden ONCOZ